LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard

The Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research (CCR) issued this sources sought notice for the procurement of one new LI-COR Biotech Odyssey M Chemi/Fluor Imaging Bundle Standard. This imaging system is required to replace an outdated protein imager currently utilized within the laboratory branch. The equipment serves as a versatile system with simplified workflows to support shared use across the laboratory and division for various intramural research projects and initiatives.

The Odyssey M system provides comprehensive applications including fluorescent and colorimetric Western blots, immunocytochemistry such as In-Cell and On-Cell Westerns, and Enzyme-Linked Immunosorbent Assays. The scope of work also encompasses protein and nucleic acid arrays, high-resolution fluorescent and Red/Green/Blue tissue section analysis, and the detection of fluorescent and colorimetric protein gels and nucleic acids. Additionally, the system supports non-isotopic Electrophoretic Mobility Shift Assays.

This requirement, identified under solicitation number SSN75N91026Q00013, is managed by the Office of the Assistant Secretary for Administration. Responses are due by May 27, 2026, and the primary place of performance is Bethesda, MD. One attachment, a Sources Sought Notice PDF, was included with the initial publication on May 21, 2026. The point of contact for this market research effort is Shayna Simpson.